Agebox Inc. sells iKids-Growth children's supplements containing the undeclared, unapproved drug ibutamoren, making them unapproved and misbranded drugs.
What happened
FDA reviewed Agebox's website and social media accounts (including Facebook) in September 2025 and also obtained samples of the two iKids-Growth products. Laboratory analysis found both samples contained ibutamoren mesylate (also called MK-677), a growth hormone secretagogue that is not FDA-approved, even though the products are labeled and marketed as dietary supplements. The labels do not disclose this ingredient.
What FDA found
The products are new drugs with no FDA-approved application, so selling them is illegal.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)The labels never say the products contain ibutamoren mesylate, so the labeling is false or misleading and the products are misbranded.
FD&C Act section 502(a), 21 U.S.C. 352(a)Ibutamoren cannot legally be used in a dietary supplement because it was studied as a new drug before being sold as a supplement.
FD&C Act section 201(ff)(3)(B)(ii), 21 U.S.C. 321(ff)(3)(B)(ii)Website and Facebook claims that the products raise IGF-1 and make children taller show they are intended to affect body structure or function, which makes them drugs.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)Shipping misbranded drugs across state lines is a prohibited act.
FD&C Act section 301(a), 21 U.S.C. 331(a)
What FDA wants
FDA asks the company to write back within 15 working days describing the specific steps taken to correct the violations and prevent them from happening again, with supporting documents. If corrections cannot be finished in that time, the company must explain why and give a completion date.
Who should pay attention
- parents and caregivers buying children's growth supplements online
- retailers and online marketplaces that list imported supplement brands
- supplement companies that buy or white-label ingredients from overseas suppliers
This is a summary. Read the original letter on fda.gov.